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Community treatment orders (CTOs) were introduced in
England in 2008. They were intended to be used to prevent
patients with severe and enduring mental health problems
deteriorating in the community and were speciﬁcally
targeted at ‘revolving-door’ patients.1 The proposed
legislation was controversial. Two large reviews2,3 failed to
ﬁnd an evidence base to support the claims made for
compulsory community treatment. One review did,
however, acknowledge the difﬁculties in conducting studies
in this area.3 The main criticisms of CTOs relate to the
restrictions that they impose on patients’ human rights.4
According to the Mental Health Act 1983, a CTO is only
an option for patients who meet the following criteria:
. the patient has a mental disorder of a nature or degree
which makes it appropriate for them to receive medical
treatment
. it is necessary for the patient’s health or safety or for the
protection of others that the patient should receive such
treatment
. subject to the patient being liable to be recalled, such
treatment can be provided without the patient continuing
to be detained in a hospital
. it is necessary that the responsible clinician should be
able to exercise the power under Section 17E(1) of the
Act to recall the patient to hospital
. appropriate medical treatment is available for the
patient.
The Mental Health Act also stipulates that the CTO
must include the conditions with which the patient is
required to comply. Two conditions are mandatory. One
requires patients to make themselves available for medical
examination for consideration of extension of the CTO, and
the other to allow a second opinion appointed doctor to
conduct a review of treatment in patients who cannot or do
not consent to treatment.
Additional conditions can also be included which are
necessary or appropriate to:
. ensure that the patient receives medical treatment for
mental disorder, or
. prevent a risk of harm to the patient’s health or safety, or
. protect other people.
Community treatment orders are akin to a contract to
which the patient agrees so that they can be allowed to
return to the community from hospital. The responsible
clinician in charge of the CTO may attach any number of
additional conditions to which the patient agrees to adhere.
These additional conditions pertain to key areas of the
patient’s care such as adherence to medication and
abstinence from drugs and alcohol.
Should the patient break this agreement and as a result
pose an increased risk or begin to show early signs of
relapse, their responsible clinician can recall them to
hospital. One of the main aims of CTOs is to intervene
early and prevent a patient relapsing.
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Aims and method To investigate the use of additional conditions attached to
community treatment orders (CTOs) and whether they inﬂuence the process of recall
to hospital. We conducted a retrospective descriptive survey of the records and
associated paperwork of all the CTOs started in the trust in the year from January
2010. Each CTO was followed up for 12 months.
Results A total of 65 CTOs were included in the study; 25 patients were recalled
during the study and all but one of these had their CTO revoked and remained in
hospital. Each patient whose CTO was revoked had experienced a relapse in their
condition. Many patients had not complied with CTO conditions prior to relapsing and
could potentially have been recalled earlier.
Clinical implications Our ﬁndings suggest that the breaching of additional CTO
conditions does not tend to result in a patient’s recall to hospital. This has implications
regarding how the workings of CTOs are explained to patients and regarding the utility
of additional conditions more generally.
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Method
Data collection
A retrospective case-note review was conducted on all
patients started on a CTO within Leeds and York Partnership
NHS Foundation Trust between January 2010 and January
2011. Patients were only excluded from the ﬁnal sample if
their case notes could not be obtained. The study was granted
approval as a service evaluation by the West Yorkshire Mental
Health and Learning Disabilities Research Partnership in
March 2011.
This sampling window of 12 months corresponded with
70 new CTOs. Data were collected for each of these CTOs
for 12 months. Where CTOs ended before 1 year (due to
discharge, revocation, etc.) the length of time for which the
patient remained on the CTO was recorded.
In addition to demographic data, we collected
information on:
. service involved (e.g. forensic, general adult)
. CTO outcome (renewed, recalled, revoked, discharged,
lapsed) along with dates
. stated conditions included
. diagnosis
. evidence of previous non-adherence
. evidence of previous substance misuse
. evidence of whether CTO conditions were reviewed or
varied
. episodes of informal admissions
. evidence of monitoring, breaches, and consequences of
breaches of conditions.
Results
Patients in the sample
Medical records were available for 65 of the initial 70 CTOs.
These 65 CTO episodes corresponded to a total of 58
patients (7 patients had two separate CTO episodes during
the study period). We decided to include these 7 CTO
episodes as when reviewed they were notably different from
the other CTO episode involving the same patient, both with
regard to the conditions included and the outcome.
The majority of CTOs were for patients who were male
(66%), aged between 30 and 35 years (mean 44, s.d. = 12.8,
range 23-83), had a psychotic illness (98%), were White
British (68%), had a history of non-adherence to anti-
psychotic medication (98%), were being treated by the
assertive outreach team (38%), and were in independent
accommodation (82%). The majority of patients (63%) did
not have a history of substance misuse. The use of depot
medication was common, with 65% of patients on CTOs
receiving antipsychotics via this route.
Characteristics of the CTOs
All but one CTO (n = 64, 98%) originated from Section 3 of
the Mental Health Act; the remaining CTOs originated from
Section 37.
Outcome of CTOs
Thirty-three CTOs (51%) were renewed and lasted for the
duration of the study; 5 patients (8%) were discharged and 3
(4%) lapsed; 25 patients were recalled during the study
period, and 24 of them had their CTO revoked.
Conditions applied
A total of 241 additional conditions (not including
mandatory conditions) were included across the 65 CTOs
in the study. The mean number of conditions per CTO was
3.7 (s.d. = 3.14, range 1-8) and the modal value was 3.
The additional conditions were grouped into six
categories (Table 1). There was some overlap between
conditions, for example separate conditions specifying that
the patient must comply with oral and depot medication.
This overlap reduced the total number of additional
conditions from 241 to 179 category-speciﬁc conditions.
The conditions of access included conditions requiring
patients to make themselves available for examination
either through home visits or clinic appointments, the
conditions of residence included conditions whereby a
patient was instructed to reside at a particular location,
and the conditions of drugs and alcohol included conditions
whereby a patient had been instructed to abstain from drugs
and alcohol and conditions that required the patient to
make themselves available for drug testing.
Of the 11 miscellaneous conditions, 4 speciﬁed that the
patient must accept help with their ﬁnances (accounting for
6 breaches), and 3 required the patient to engage with other
professionals (e.g. probation), accounting for a further 2
breaches. One attached a requirement to engage in one
meaningful activity daily and resulted in three breaches.
Monitoring of conditions
The extent to which conditions were monitored varied
between categories. All patients on depot medication had
monitoring recorded; of those on oral medication, 82% had
some evidence of monitoring taking place, commonly
relying on patients’ self-reports. In every case where a
condition of access was stated, there was evidence that the
clinical team made attempts to engage the patient and
arranged out-patient appointments. Those with a condition
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Table 1 Frequency and outcome of additional
CTO conditions
Condition
Frequency
n
Breaches
n
Recalls
n (%)a
Medication 65 43 4 (9)
Access 64 22 3 (14)
Residence 19 2 0
Drugs and alcohol 15 17 1 (0.6)
Medication monitoring 5 0 0
Miscellaneous 11 11 0
Total 179 95 8 (8)
CTO, community treatment order.
a. The recalls relate only to those which were associated with the breach of a
condition. The actual number of recalls in the study was 24.
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of residence were monitored only if they were in supported
accommodation. Of the 15 patients with a condition of drugs
and alcohol, only 7 had evidence of monitoring taking place.
Breaches of conditions
There were 95 breaches across the 179 conditions (Table 1).
The largest number of breaches occurred in the medication
condition, followed by the condition of access, then the
condition of drugs and alcohol. The drugs and alcohol
category had the largest proportion of breaches (17 breaches
out of 15 conditions).
Only 8 patients were recalled following a breach of one
of their conditions, and 7 of them had relapsed by the time
they returned to hospital. A further two patients were
admitted informally. In the majority of cases a breach led to
the patient being reminded that they were expected to
comply with the conditions.
Discussion
Limitations
The main limitations relate to the measurement and
recording of the data. The data collection method was
limited to case records. The results of this study can only
reﬂect what was recorded by staff and it is likely that some
information failed to be recorded. This issue was addressed
to some extent by the use of both computer and paper
records, along with data routinely collected by the Trust’s
Mental Health Act Ofﬁce. It is possible that this method
underestimated both the degree of monitoring and the
number of breaches that occurred.
Characteristics of study sample
Patients on CTOs are typically males, around 40 years of
age, with a long history of mental illness, previous
admissions, with schizophrenia-like or serious affective
illness. Our sample characteristics were consistent with
these international ﬁndings.2
The characteristics of the sample are very similar to
those seen in other parts of the UK,5-8 suggesting
generalisability of results nationally.
Main ﬁndings
A total of 179 category-speciﬁc conditions were identiﬁed in
the sample. The average (modal) number of conditions per
CTO was three. We recorded 95 breaches of additional
conditions during the study period. Only eight patients were
recalled following the breach of an additional condition, and
seven of these had relapsed by the time they arrived in
hospital.
A total of 25 patients were recalled during the study
period, and 24 of the 25 had their CTO revoked and
remained in hospital under Section 3 of the Mental Health
Act because they had relapsed. This ﬁnding is consistent
with the data from other years within the Trust: from
November 2008 (when CTOs were ﬁrst introduced) to
February 2012 there were a total of 57 recalls and 56
revocations. Other reported data9 provide an overview of all
uses of CTOs in England. From November 2008 to April
2011 there were a total of 10 071 new CTOs. Of these, there
were 3025 recalls and 1940 CTOs were revoked. This
suggests that on average 64% of patients recalled will then
have their CTO revoked and remain in hospital on Section 3.
This ﬁgure is lower than that found in the current study, but
is still surprisingly high.
Both the revocation rate and the fact that breached
conditions only rarely led to recall is interesting. We suggest
that this might in part relate to how the law governing
CTOs is interpreted. According to Section 17E(1) of the
Mental Health Act, the responsible clinician may recall a
community patient on a CTO to hospital if in their opinion:
(a) the patient requires medical treatment in hospital for
their mental disorder, and
(b) there would be a risk of harm to the health or safety of
the patient or other persons if the patient were not
recalled to hospital for that purpose.
Therefore, only if the breach of the condition is associated
with an increase in risk can the recall be justiﬁed. It is not
clear whether the risk must be immediate to permit a lawful
recall or whether a patient can be recalled based on the
prediction that certain behaviours will lead to risk being
present in the near future. The ﬁndings from our study
suggest that clinicians interpret the risk of harm to be
immediate. There are cases, however, where it is reasonable
to predict that if the patient breaches a condition (for
example, refuses their depot medication or misuses drugs),
they will relapse relatively quickly and a risk of harm will
soon follow that may not be mitigated by action from their
clinical team. In our opinion, in such cases, the wording of
Section 17E(1) permits clinicians to recall patients before
they have relapsed based on the nature of their illness.
Furthermore, if the risk stated in Section 17E(1) is taken to
be immediate, then it follows that the patient must have
demonstrated signs of relapse before recall, thus rendering
CTOs ineffective at preventing relapse, one of their core
aims.
In addition to the way in which Section 17E(1) is
interpreted there are likely to be other reasons why
clinicians wait until a patient has shown signs of relapse
before recalling them. First, this has been the approach for
many years and such a departure from routine practice may
be too much of a challenge to the prevailing culture. Second,
clinicians must balance the need to contain immediate risks
with the need to preserve a therapeutic relationship with
the patient, which is essential to manage risks in the longer
term.
Despite the issues surrounding the recall of patients on
CTOs, supervised community treatment has potential
beneﬁts. A cohort of patients appear to adhere to conditions
out of concern that if they do not, they will be recalled,
often resulting in improved mental health and reduced risk.
Such behaviour was certainly observed in this study and it is
reﬂected by experience in clinical practice. However, given
that our study ﬁndings suggest that simply breaching
conditions will not result in recall, it is arguable that such
an approach, although bringing with it beneﬁts for the
patient, is overly paternalistic and is not in keeping with a
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culture of respecting human rights and being open with
patients.
We recommend that clinicians should only include
additional conditions that they would act on should the
patient fail to comply. Such an approach will introduce
clarity for both the patient and other members of the
clinical team. It will also avoid the risk of the more
important conditions being diluted by the patient’s
experience of breaching other conditions without conse-
quence. Additionally, the inclusion of conditions that are
unlikely to lead to recall could be considered an
unnecessary restriction on the patient and such practice is
inconsistent with the principles of the Mental Health Act’s
Code of Practice.10
Clinical implications
Since their introduction in 2008, CTOs have become an
increasingly common way to manage ‘revolving-door’
patients in the community. This is despite the lack of a
clear evidence base to support their use. Additional
conditions, which place restrictions on the patient, are
considered an appropriate and necessary part of CTOs and
are routinely included.
The high recall to relapse rate ratio recorded in this
study suggests that responsible clinicians wait until patients
show signs of relapse before recalling them. We suggest that
this may occur for a number of reasons but most
importantly it is due to the way in which the law governing
CTOs is worded and interpreted. Our interpretation of the
law is that CTOs do provide a legal mechanism which
enables a patient to be recalled to hospital before they
relapse, based on the nature of their illness.
The effectiveness of additional conditions, in part,
relies on the patient’s belief that if they breach conditions,
they will be recalled to hospital. This does not appear to be
borne out in practice, however, and additional conditions
tend to contribute little to the decision to recall a patient on
a CTO. Although it may improve a patient’s mental health,
to imply that the breach of a condition will result in recall
when this is likely not to be the case is akin to providing a
placebo and raises ethical issues.
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